


Dualitas Therapeutics Revenue
Biotechnology Research • • 11-20 Employees
Dualitas Therapeutics revenue & valuation
| Annual revenue | $1,283,325 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $4,200,000 |
| Total funding | $65,000,000 |
Key Contacts at Dualitas Therapeutics
Daniel Kalb
Director Of Operations & Strategic Finance
Brandon Leonard
Director - Biotherapeutics
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Founded | 2023 |
| Employees | 11-20 |
Dualitas Therapeutics Email Formats
Dualitas Therapeutics uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 42.1% |
{first name}@company.com | john@company.com | 25.3% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 14.8% |
{first name}{last name}@company.com | johndoe@company.com | 10.2% |
{last name}@company.com | doe@company.com | 7.6% |
About Dualitas Therapeutics
Dualitas Therapeutics is a biotechnology company pioneering the future of bispecific antibody therapies for immune and inflammatory (I&I) diseases and beyond. Powered by our proprietary DualScreen™ discovery engine and a growing library of novel cell surface proximity engagers, our pipeline—including lead programs DTX-103 and DTX-102—has demonstrated compelling preclinical evidence supporting its potential to address important unmet patient needs. We offer partnering opportunities on the next generation of bispecific therapies in I&I diseases – and beyond.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Dualitas Therapeutics has 6 employees across 4 departments.
Departments
Number of employees
Frequently asked questions
4.8
40,000 users



